Anti-CD79b Reference Antibody (polatuzumab vedotin-piiq), IgG1

Catalog Number: SYB-CHB256
Article Name: Anti-CD79b Reference Antibody (polatuzumab vedotin-piiq), IgG1
Biozol Catalog Number: SYB-CHB256
Supplier Catalog Number: CHB256
Alternative Catalog Number: SYB-CHB256-100UG,SYB-CHB256-1MG
Manufacturer: Sanyou Bio
Category: Antikörper
Application: ELISA, FA, FACS, Kinetics
Species Reactivity: Human
Alternative Names: RG7596, DCDS4501A, huMA79b.v28
Polatuzumab vedotin (Polivy) is an ADC consisting of a CD79b-directed antibody and Monomethyl auristatin E (MMAE) that can be used in combination with bendamustine and rituximab for the treatment of adult patients with at least two relapses or refractory diffuse large B-cell lymphoma. Polatuzumab vedotin binds to CD79b and is internalized by tumor cells. MMAE is cleaved from cells by lysosomal protease and promotes tumor cell apoptosis by inhibiting microtubule formation.
Concentration: 1mg/ml
Molecular Weight: 150.53 kDa
Isotype: IgG1
NCBI: 40259
UniProt: P40259
Buffer: 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
Purity: >90%
Form: Lyophilize
Target: CD79b